Professor Marcus Franz

Prognostic relevance of mitral regurgitation at different follow-up timepoints after transcatheter aortic valve implantation (TAVI): implications for therapeutic decision making?

Event: ESC Congress 2022

Topic: Intervention

Session: Challenges in transcatheter aortic valve intervention

Access

0

Tricuspid regurgitation and atrial fibrillation at baseline independently predict two-year survival after transcatheter aortic valve implantation (TAVI)

Event: ESC Congress 2022

Topic: Intervention

Session: Challenges in transcatheter aortic valve intervention

Access

0

Chronic cardiac allograft rejection after heterotopic rat heart transplantation: ed-a but not ed-b domain containing fibronectin as novel serum biomarker of cardiac allograft vasculopathy

Event: ESC CONGRESS 2019

Topic: Heart Transplantation

Session: Heart Failure Basic Science

Access

0

Pre-existing depression significantly improves after transcatheter aortic valve implantation (TAVI): analysis of long-term effects and screening for novel biomarkers

Event: ESC CONGRESS 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Aortic valve interventions

Access

0

Heart failure in aortic stenosis: extra-valvular cardiac damage according to the novel 2017 staging classification is differentially reflected by certain biomarkers of cardiovascular remodelling

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Pathophysiology and Mechanisms

Session: Valvular Heart Disease

Access

0

Serum levels of fetal tenascin-C variants as novel biomarkers reflecting vascular remodeling and right ventricular dysfunction in pulmonary hypertension

Event: ESC CONGRESS 2017

Topic: Chronic pulmonary hypertension

Session: Pulmonary hypertension, congenital and acquired

Access

0

Pharmacological inhibition of arginase activity in a rat model of monocrotaline-induced pulmonary hypertension.

Event: ESC CONGRESS 2017

Topic: Treatment of hypertension

Session: Hypertension drug treatment

Access

0

Professor Marcus Franz

Contributor content

Prognostic relevance of mitral regurgitation at different follow-up timepoints after transcatheter aortic valve implantation (TAVI): implications for therapeutic decision making?

Tricuspid regurgitation and atrial fibrillation at baseline independently predict two-year survival after transcatheter aortic valve implantation (TAVI)

Chronic cardiac allograft rejection after heterotopic rat heart transplantation: ed-a but not ed-b domain containing fibronectin as novel serum biomarker of cardiac allograft vasculopathy

Pre-existing depression significantly improves after transcatheter aortic valve implantation (TAVI): analysis of long-term effects and screening for novel biomarkers

Heart failure in aortic stenosis: extra-valvular cardiac damage according to the novel 2017 staging classification is differentially reflected by certain biomarkers of cardiovascular remodelling

Serum levels of fetal tenascin-C variants as novel biomarkers reflecting vascular remodeling and right ventricular dysfunction in pulmonary hypertension

Pharmacological inhibition of arginase activity in a rat model of monocrotaline-induced pulmonary hypertension.

ESC 365 is supported by